Drug
Vesicare Betmiga
Vesicare Betmiga: highest development phase Phase 1, developed by Hikma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hikma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose) NCT05767632 | Phase 1 | Healthy |
Latest
No recent events.
Follow Vesicare Betmiga on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.